Clinical Trials in Texas

Showing 5401-5420 of 11,487 trials

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

NCT00437255

Evaluate the efficacy of Clobex® Spray as compared to Taclonex® Ointment in terms of Overall Disease Severity and Investigator Global Assessment.

Plaque Psoriasis

Galderma R&D122 participantsStarted Aug 2006

Fridley, Minnesota, United States • Austin, Texas, United States • Bryan, Texas, United States +1 more locations

COMPLETEDPhase 455 miles

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

NCT00469755

To determine the efficacy and safety of 12 weeks of treatment with Differin Gel, 0.1% compared to 12 weeks of treatment with Tazorac Cream, 0.1% and compared to 6 weeks treatment with Differin Gel, 0.1% followed by 6 weeks of treatment with Tazorac Cream

Acne Vulgaris

Galderma R&D302 participantsStarted Feb 2006

San Diego, California, United States • Detroit, Michigan, United States • Fridley, Minnesota, United States +9 more locations

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

Find Trials by Condition in Texas

ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment

Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Treatment for COVID-19 in High-Risk Adult Outpatients

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients

USCRI READY4Life Program

A Study of LY3561774 in Participants With Dyslipidemia

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects